Intro To Our New Weight Loss Program

Semaglutide Overview

Semaglutide Information

  • Wegovy® was FDA approved as a weight loss drug after it’s predecessor, semaglutide (Ozempic®) was noted to lead to weight loss in diabetic patients.

  • Semaglutide works via mimicking (agonist) GLP-1 (glucagon like peptide) to increase insulin secretion to increase sugar metabolism, but also signals your brain to decrease appetite.

  • Although there are going to be several competitors on the market soon based on this concept, right now, semaglutide has the highest risk benefit ratio of all weight loss drugs.

Instructional Videos

Semaglutide Packet

pdf

Semaglutide Consent

pdf

Next Steps

pdf

Patient Experiences